• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TOTAL PSA ELECSYS E2G 300 V2; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TOTAL PSA ELECSYS E2G 300 V2; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08791732190
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/27/2021
Event Type  malfunction  
Manufacturer Narrative
The sample was requested for investigation, however, the sample has been discarded by the customer.As no sample was available for investigation, the cause of the event could not be determined.The investigation did not identify a product problem.
 
Event Description
The initial reporter questioned results for 1 patient sample tested for total psa elecsys e2g 300 v2 (total psa) and free psa elecsys e2g 300 v2 (free psa) on a cobas e801 analytical unit.This medwatch will cover total psa.Refer to medwatch with patient identifier (b)(6) for information on the free psa results.The initial free psa result was 0.0259 ng/ml and the initial total psa result was 0.0067 ng/ml.The initial results were reported outside of the laboratory where the clinicians questioned the results as a free psa result greater than a total psa was believed to be "impossible." on (b)(6) 2021 the sample was repeated with a free psa result of 0.0268 ng/ml and a total psa result of 0.00908 ng/ml.Qc was acceptable, however, calibration had "expired." the customer recalibrated both assays and ran acceptable qc.The sample was repeated again and the free psa result was 0.0100 ng/ml with a data flag and the total psa result was 0.00600 with a data flag ng/ml.The e801 analyzer serial number was (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL PSA ELECSYS E2G 300 V2
Type of Device
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12666991
MDR Text Key277712051
Report Number1823260-2021-03072
Device Sequence Number1
Product Code LTJ
UDI-Device Identifier07613336165980
UDI-Public07613336165980
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number08791732190
Device Lot Number49236103
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-